tweetindex
PT

C. Michael Gibson MD ✓

@CMichaelGibson · Harvard Professor & MD · joined 14 Oct 2012

Non-Profit Founder/Leader | ❤️ Doc | Artist Scientist Educator | News Anchor https://t.co/7OIKCgNtqr | RT ≠ endorse | Disclaimer: https://t.co/bwmE2O4rVu

429 621Followers
360 146Following
89 107Posts total
399.7KViews on collected posts

Posts recentes

@CMichaelGibson Makes you wonder if study patients' LDL-C is reasonably well-controlled with statins, PCSK9i, BA, EZE how much residual risk is actually there with abnormal (high) LP(a)? 4.2K views · 20 likes · 0 reposts · 4 replies Open on X →
@CMichaelGibson @DrR_Jabbour Bad month for coronary prevention trials across 3 different domains— inflammation, factor XI inhibition, and now LPa. Looks like I’m going to need to keep taking STEMI call for a while. 9.2K views · 113 likes · 7 reposts · 6 replies Open on X →
Breaking and MASSIVE: Lowering Lp(a) with #pelacarsen in patients with elevated Lp(a) and heart disease does NOT improve cardiovascular outcomes in Phase 3 trial https://t.co/QrN5I3NNlc 208.4K views · 578 likes · 166 reposts · 46 replies Open on X →
@CMichaelGibson Prof. Gibson, pull this up today 😁 Why does drinking and showering in Metalloestrogens,VOC's, Xenoestrogens and PFAS chemicals on a daily basis cause Obesity, and T2DM? Sir, do they cause "cell membrane" and Organelle degradation? Yes or Yes? GLP-1 has adverse 14 views · 1 likes · 0 reposts · 0 replies Open on X →
The recording from today's Baim Grand Rounds and the Inaugural Da Vinci Lecture with Dr. Gary Mintz, on "Imaging and ALCHEMIA: Making Something from Nothing," is now available on the Baim website. You can find it here: https://t.co/l0pQuouYrq https://t.co/4i1y4KDSnL 2.8K views · 16 likes · 3 reposts · 1 replies Open on X →
@CMichaelGibson This is why it's so important for people to have consistent cheap access to GLP-1 medications, they improve health and longevity in so many ways. Fortunately a year's supply is under $200 if you buy direct. Just need to know where to look. https://t.co/yYlfGdT3m 69 views · 2 likes · 0 reposts · 0 replies Open on X →
Reminder! Join us in 30 minutes at 9:30 am ET for the Inaugural Da Vinci Lecture and Baim Grand Rounds with Dr. Gary S. Mintz, presenting "Imaging and ALCHEMIA: Making Something from Nothing.” Zoom link: https://t.co/wwabV1H6cU https://t.co/QQXt7kgpqM 3K views · 14 likes · 3 reposts · 0 replies Open on X →
Can GLP-1 drugs slow ageing? Mouse study shows promise https://t.co/TPCKGbk3Py 6.3K views · 36 likes · 6 reposts · 2 replies Open on X →
@CMichaelGibson always worth clearing the calendar for a Mintz lecture intravascular imaging talks from someone with this much experience are rare to catch live 36 views · 2 likes · 0 reposts · 0 replies Open on X →
Reminder! Join us on Thursday, September 3, 2026, from 9:30-10:30 am for the Inaugural Da Vinci Lecture and Baim Grand Rounds with Dr. Gary S. Mintz, presenting "Imaging and ALCHEMIA: Making Something from Nothing.” Zoom link: https://t.co/wwabV1HE2s https://t.co/Wa9LrTzeWb 3.9K views · 13 likes · 4 reposts · 1 replies Open on X →
@CMichaelGibson Interesting findings on anticoagulation in atrial fibrillation. 🫀🩺 Evidence like this can help guide safer, more informed stroke-prevention decisions. 2.4K views · 1 likes · 0 reposts · 0 replies Open on X →
@CMichaelGibson @DrSaririan They were going to call it National Outcomes Study of High Intensity Treatment 3.6K views · 22 likes · 1 reposts · 0 replies Open on X →
@CMichaelGibson The name of this trial is a joke, right? 2.6K views · 16 likes · 0 reposts · 1 replies Open on X →
SINGLE-AF trial: In patients with atrial fibrillation and intermediate stroke risk, DOAC therapy lowered the risk of net adverse clinical events (stroke, systemic embolism, major bleeding, or CV death) compared to no anticoagulation at 24 months. View slides here: https://t.co/gT
153.1K views · 270 likes · 51 reposts · 4 replies Open on X →
“The Last Shift” Oil on clay covered wood board by C. Michael Gibson 2020. Welcome home to all of our courageous #CoronaHeroes who made the ultimate sacrifice 🙏💙 #cmgsees #COVID19 https://t.co/lg9GBLq4Ps 0 views · 3.3K likes · 804 reposts · 290 replies Open on X →

Em comparação com contas do mesmo porte

14 posts dos últimos 90 dias, ao lado da faixa de 100K–1M seguidores. abaixo dos pares tanto em alcance quanto em engajamento.

Mediana de visualizações3 299esta conta5 983mediana para 100K–1M
Alcance, %0.77%esta conta1.49%mediana para 100K–1M
Engajamento, %0.64%esta conta0.93%mediana para 100K–1M
MétricaEsta contaMediana para 100K–1MProporção
Mediana de visualizações por post3 2995 9830.55×
Alcance (visualizações ÷ seguidores)0.77%1.49%0.52×
Taxa de engajamento0.64%0.93%0.69×

Outras contas desta faixa →   Comparar com outra conta →   Como estas referências são construídas →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

153.1K28 Aug
2.6K29 Aug
3.6K
2.4K
3.9K2 Sep
36
6.3K3 Sep
3K
69
2.8K
144 Sep
208.4K
9.2K
4.2K

Last 14 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.24%28 Aug
0.65%29 Aug
0.64%
0.04%
0.46%2 Sep
5.56%
0.70%3 Sep
0.57%
2.90%
0.71%
7.14%4 Sep
0.40%
1.37%
0.57%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 100K–1M accounts is 0.93%.

What the audience does

Likes59.6%1 104 in total
Reposts13.0%241 in total
Replies3.5%65 in total
Quotes4.3%79 in total
Bookmarks19.6%363 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Contas semelhantes